Dysregulated L-glu and PA showed adequate diagnostic performance in differentiating MetS(+) HCC from MetS(+) individuals, and the combination of L-glu, PA and AFP exhibited much better diagnostic performance than AFP alone. The gene discussed is AFP; the disease is hepatocellular carcinoma.